| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
From the Veteran’s Administration Medical Center Ann Arbor,* Ann Arbor, Michigan; the Department of Internal Medicine, Division of Pulmonary and Critical Care Medicine, The University of Michigan Medical School, Ann Arbor, Michigan; and the Department of Internal Medicine, Division of Infectious Diseases, Duke University Medical Center, Durham, North Carolina
Our objective was to determine the role of the cryptococcal virulence factor urease in pulmonary-to-central nervous system, dissemination, invasion, and growth. C. neoformans H99, the urease knockout strain (ure1) derived from H99, and the urease restored strain ure1+URE1–1 were used for thestudies. The absence of cryptococcal urease (ure1infection) resulted in significant protection from the high mortality observed in H99-infected mice. All H99-infected mice had extremely high cryptococcal loads in their brains at the time of death, whereas only two of six animals that died of ure1 infection had detectable C. neoformans in the brain. Histological analysis of the blood-to-brain invasion by C. neoformans H99 demonstrated wedging of the yeasts in small capillaries, altered structure of microvessel walls, formation of mucoid cysts initiated in the proximity of damaged microcapillaries, and the absence of an inflammatory response. Direct inoculation of H99, ure1, and ure1+URE1–1 into the brain demonstrated that urease was not required to grow in the brain. However, the dissemination patterns in the brain, spleen, and other organs after intravenous inoculation indicated that cryptococcal urease contributes to the central nervous system invasion by enhancing yeast sequestration within microcapillary beds (such as within the brain) during hematogenous spread, thereby facilitating blood-to-brain invasion by C. neoformans.
This article has been cited by other articles:
 |
|
 |
|
  C.-Y. HUNG, J. XUE, and G. T. COLE Virulence Mechanisms of Coccidioides Ann. N.Y. Acad. Sci., September 1, 2007; 1111(1): 225 - 235. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Varma, S. Wu, N. Guo, W. Liao, G. Lu, A. Li, Y. Hu, G. Bulmer, and K. J. Kwon-Chung Identification of a novel gene, URE2, that functionally complements a urease-negative clinical strain of Cryptococcus neoformans Microbiology, December 1, 2006; 152(12): 3723 - 3731. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. G. da Silva, F. d. A. Baroni, F. C. Viani, L. d. S. Ruiz, R. F. Gandra, M. E. Auler, A. L. T. Dias, W. Gambale, and C. R. Paula Virulence profile of strains of Cryptococcus neoformans var. grubii evaluated by experimental infection in BALB/c mice and correlation with exoenzyme activity J. Med. Microbiol., February 1, 2006; 55(2): 139 - 142. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Mirbod-Donovan, R. Schaller, C.-Y. Hung, J. Xue, U. Reichard, and G. T. Cole Urease Produced by Coccidioides posadasii Contributes to the Virulence of This Respiratory Pathogen Infect. Immun., January 1, 2006; 74(1): 504 - 515. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Nielsen, G. M. Cox, A. P. Litvintseva, E. Mylonakis, S. D. Malliaris, D. K. Benjamin Jr., S. S. Giles, T. G. Mitchell, A. Casadevall, J. R. Perfect, et al. Cryptococcus neoformans {alpha} Strains Preferentially Disseminate to the Central Nervous System during Coinfection Infect. Immun., August 1, 2005; 73(8): 4922 - 4933. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Charlier, F. Chretien, M. Baudrimont, E. Mordelet, O. Lortholary, and F. Dromer Capsule Structure Changes Associated with Cryptococcus neoformans Crossing of the Blood-Brain Barrier Am. J. Pathol., February 1, 2005; 166(2): 421 - 432. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
